TickerFacts.

A business in context

RYTM research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-14 · 0001649904-26-000026

  2. 4 · Ownership change

    Report date 2026-08-31 · 0001649904-26-000023

  3. 4 · Ownership change

    Report date 2026-08-17 · 0001649904-26-000020

  4. 4 · Ownership change

    Report date 2026-08-13 · 0001649904-26-000015

  5. 4 · Ownership change

    Report date 2026-08-13 · 0001649904-26-000013

  6. 4 · Ownership change

    Report date 2026-08-13 · 0001649904-26-000009

  7. 4 · Ownership change

    Report date 2026-08-12 · 0001649904-26-000007

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-052533

  9. 8-K · Current report

    Report date 2026-08-04 · 0001628280-26-052170 · Items 2.02,7.01,8.01,9.01

  10. 4 · Ownership change

    Report date 2026-07-01 · 0001104659-26-080397

  11. 8-K · Current report

    Report date 2026-06-24 · 0001628280-26-045569 · Items 5.07

  12. 8-K · Current report

    Report date 2026-06-13 · 0001628280-26-043170 · Items 7.01,8.01,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-030549

  14. 8-K · Current report

    Report date 2026-05-05 · 0001628280-26-030136 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-24 · 0001628280-26-028375

  16. 8-K · Current report

    Report date 2026-04-01 · 0001628280-26-023606 · Items 5.02,7.01,9.01

  17. 8-K · Current report

    Report date 2026-03-26 · 0001628280-26-021414 · Items 7.01,8.01,9.01

  18. 8-K · Current report

    Report date 2026-03-19 · 0001628280-26-019995 · Items 7.01,8.01,9.01

  19. 8-K · Current report

    Report date 2026-03-16 · 0001628280-26-018211 · Items 7.01,8.01,9.01

  20. 8-K · Current report

    Report date 2026-03-02 · 0001104659-26-021801 · Items 7.01,8.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-012399

  22. 8-K · Current report

    Report date 2026-02-26 · 0001628280-26-011987 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-01-09 · 0001628280-26-001459 · Items 2.02,7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2025-12-16 · 0001104659-25-123108 · Items 5.02

  25. 8-K · Current report

    Report date 2025-12-11 · 0001104659-25-120141 · Items 7.01,8.01,9.01

  26. 8-K · Current report

    Report date 2025-11-06 · 0001104659-25-108154 · Items 7.01,8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-106264

  28. 8-K · Current report

    Report date 2025-11-04 · 0001104659-25-105904 · Items 2.02,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010302

  30. 8-K · Current report

    Report date 2025-08-05 · 0001558370-25-010176 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-07-09 · 0001104659-25-067133 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2025-07-09 · 0001104659-25-066724 · Items 7.01,8.01,9.01

  33. 8-K · Current report

    Report date 2025-06-24 · 0001558370-25-008924 · Items 5.03,5.07,9.01

  34. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-006765

  35. 8-K · Current report

    Report date 2025-05-07 · 0001558370-25-006602 · Items 2.02,9.01

  36. DEF 14A · Proxy statement

    Report date 2025-06-24 · 0001558370-25-005818

  37. 8-K · Current report

    Report date 2025-04-07 · 0001558370-25-004507 · Items 7.01,8.01,9.01

  38. 8-K · Current report

    Report date 2025-03-14 · 0001558370-25-003374 · Items 1.02,7.01,9.01

  39. 8-K · Current report

    Report date 2025-02-27 · 0001558370-25-001891 · Items 8.01

  40. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-001889

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 20 transaction rows20SGrant / award: 2 transaction rows2AExercise / conversion: 14 transaction rows14MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

37 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-14
2026-09-14
Meeker David P
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2300.0105.19
2026-09-14
2026-09-14
Meeker David P
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6439.0101.75
2026-09-14
2026-09-14
Meeker David P
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock30746.0102.35
2026-09-14
2026-09-14
Meeker David P
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8698.0103.43
2026-09-14
2026-09-14
Meeker David P
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1817.0104.55
2026-09-14
2026-09-14
Meeker David P
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock50000.06.05
2026-09-14
2026-09-14
Meeker David P
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (Right to Buy)
Derivative security
50000.00.0
2026-08-31
2026-09-01
Smith Hunter C
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11514.0105.37
2026-08-31
2026-09-01
Smith Hunter C
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock23072.0104.59
2026-08-31
2026-09-01
Smith Hunter C
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock57187.025.79
2026-08-31
2026-09-01
Smith Hunter C
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock28188.0106.2
2026-08-31
2026-09-01
Smith Hunter C
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (Right to Buy)
Derivative security
57187.00.0
2026-08-17
2026-08-18
Joshi ManherA · Grant / award
Acquired
Restricted Stock Units
Derivative security
25000.00.0
2026-08-17
2026-08-18
Joshi ManherA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
50000.00.0
2026-08-13
2026-08-17
Shulman Joseph
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5079.0119.75
2026-08-13
2026-08-17
Shulman Joseph
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock2024.06.8
2026-08-13
2026-08-17
Shulman Joseph
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Options (Right to Buy)
Derivative security
2024.00.0
2026-08-13
2026-08-17
Garfield Alastair
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1556.0117.08
2026-08-13
2026-08-17
Garfield Alastair
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock800.0119.17
2026-08-13
2026-08-17
Garfield Alastair
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2007.0116.11
2026-08-13
2026-08-17
Garfield Alastair
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3400.0118.28
2026-08-13
2026-08-14
Lee Jennifer Kayden
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock75834.0117.38
2026-08-13
2026-08-14
Lee Jennifer Kayden
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock35000.024.29
2026-08-13
2026-08-14
Lee Jennifer Kayden
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock21601.06.8
2026-08-13
2026-08-14
Lee Jennifer Kayden
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Options (Right to Buy)
Derivative security
35000.00.0
2026-08-13
2026-08-14
Lee Jennifer Kayden
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Options (Right to Buy)
Derivative security
21601.00.0
2026-08-12
2026-08-14
Mazabraud Yann
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock14568.0115.43
2026-08-12
2026-08-14
Mazabraud Yann
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock18208.0116.49
2026-08-12
2026-08-14
Mazabraud Yann
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock17319.0117.47
2026-08-12
2026-08-14
Mazabraud Yann
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1000.0112.86
2026-08-12
2026-08-14
Mazabraud Yann
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2300.0111.8
2026-08-12
2026-08-14
Mazabraud Yann
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock46625.06.8
2026-08-12
2026-08-14
Mazabraud Yann
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3605.0114.7
2026-08-12
2026-08-14
Mazabraud Yann
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Options (Right to Buy)
Derivative security
46625.00.0
2026-07-01
2026-07-02
Garfield AlastairM · Exercise / conversion
Acquired
Common Stock4445.0n/a
2026-07-01
2026-07-02
Garfield AlastairF · Tax / exercise payment
Disposed
Common Stock2150.0110.41
2026-07-01
2026-07-02
Garfield AlastairM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
4445.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001649904RHYTHM PHARMACEUTICALS, INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
529900JPNWXQ8DPLA551
GLEIF legal name
Rhythm Pharmaceuticals, Inc.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-10-07T10:49:01Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Rhythm (United states) · alias · wikidata
  • Rhythm Pharmaceuticals · alias · wikidata
  • RHYTHM METABOLIC, INC. · former SEC name · 2015-08-12 to 2015-08-12
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$130.13M$139.77M
2023-12-31$77.43M$85.61M
2022-12-31$23.64M$27.21M
2021-12-31$3.15M$3.92M
2020-12-31$0$0
2019-12-31$0$0
2018-12-31$0$0
2017-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗